Announcements Trials
Browse Landscape

Status

Completed 7Recruiting 6Active not recruiting 4Unknown 2

Sponsor Class

INDUSTRY 4OTHER 2

Study Type

Interventional 45Observational 6

Sponsor

Cancer Type

Breast 6

Conditions

Breast Neoplasms 6Neoplasm Metastasis 1Breast Neoplasms, Male 1Breast Diseases 1

Interventions

Blood Specimen Collection 123Surveys and Questionnaires 82Observation 49Radiotherapy 40Surgical Procedures, Operative 34Drug Therapy 34Biopsy 31Specimen Handling 28Data Collection 27Watchful Waiting 20Interviews as Topic 20Magnetic Resonance Imaging 18Immune Checkpoint Inhibitors 17Liquid Biopsy 16Magnetic Resonance Spectroscopy 15Immunotherapy 15Standard of Care 13pembrolizumab 12Tomography, X-Ray Computed 12Ultrasonography 11trastuzumab deruxtecan 10lenvatinib 10Radiosurgery 10Nivolumab 10Neoadjuvant Therapy 10Carboplatin 10Tissue Banks 9Restraint, Physical 9Radiation 9Endoscopy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Observational × ribociclib × Clear all
NCT06930859 2026-05-22

ELEGANCE

Novartis

Recruiting
2,766 enrolled
Breast

Breast Neoplasms

NCT06830720 2026-05-08

CAROLEEN

Novartis

Recruiting
3,250 enrolled
Breast

Breast Neoplasms

NCT06905301 2026-05-05

IMPULSE

Novartis

Recruiting
240 enrolled
Breast

Breast Neoplasms

NCT06797531 2026-02-04

NISLEESA

Novartis

Recruiting
177 enrolled
Breast

Breast Neoplasms

NCT06805812 2025-02-03

PALMARES-2

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Recruiting
3,500 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Breast Neoplasms, Male

NCT06587789 2024-11-21

Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Recruiting
286 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡